Actively Recruiting
Exercise and Nutrition for Healthy AgeiNg
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-06-28
180
Participants Needed
1
Research Sites
380 weeks
Total Duration
On this page
Sponsors
U
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
K
KU Leuven
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this randomized placebo-controlled 5-arm clinical trial is to evaluate the effect of combined anabolic interventions compared to single or placebo interventions on physical performance in community-dwelling (pre)sarcopenic elderly (≥ 65 years) and to determine the underlying mechanisms of action. Important secondary outcome measures are muscle mass, muscle strength, compliance to the interventions (exercise program, protein and omega-3 supplementation) and functional, cognitive and nutritional status.
CONDITIONS
Official Title
Exercise and Nutrition for Healthy AgeiNg
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female persons with (pre)sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP), including reduced muscle mass with or without reduced walking speed or muscle strength
- 65 years or older
- Community-dwelling elderly or assisted living
- If health screen for exercise shows positive answers, approval from general practitioner is required
You will not qualify if you...
- Impairments or diseases that prevent participation in the study
- Allergy to milk, soy, or peanut
- Mini-Mental State Examination (MMSE) score less than 21
- Terminal illness with prognosis less than 6 months
- Participation in a physical training program twice or more per week in the last 6 months
- Daily protein intake greater than 1.5 g/kg body weight
- Diagnosis of severe kidney disease (GFR less than 30 ml/min) or diabetes mellitus
- Unable to communicate in Dutch, English, or French
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gerontology and Geriatrics, Department of Public Health and Primary Care, KU Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
Research Team
L
Laur Vercauteren, MSc
CONTACT
J
Jolan Dupont, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here